Free Trial

Bright Health Group (BHG) Competitors

Bright Health Group logo
$6.83 +0.03 (+0.44%)
As of 07/11/2025

BHG vs. LRMR, CRGX, MDWD, SCPH, SLS, ACIU, DSGN, KOD, SXTC, and ELDN

Should you be buying Bright Health Group stock or one of its competitors? The main competitors of Bright Health Group include Larimar Therapeutics (LRMR), CARGO Therapeutics (CRGX), MediWound (MDWD), scPharmaceuticals (SCPH), SELLAS Life Sciences Group (SLS), AC Immune (ACIU), Design Therapeutics (DSGN), Kodiak Sciences (KOD), China SXT Pharmaceuticals (SXTC), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "medical" sector.

Bright Health Group vs. Its Competitors

Bright Health Group (NYSE:BHG) and Larimar Therapeutics (NASDAQ:LRMR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

91.9% of Larimar Therapeutics shares are owned by institutional investors. 58.4% of Bright Health Group shares are owned by insiders. Comparatively, 4.5% of Larimar Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Larimar Therapeutics has lower revenue, but higher earnings than Bright Health Group. Larimar Therapeutics is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bright Health Group$2.76B0.02-$1.46B-$208.73-0.03
Larimar TherapeuticsN/AN/A-$80.60M-$1.49-2.27

Larimar Therapeutics has a consensus target price of $18.50, suggesting a potential upside of 447.34%. Given Larimar Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Larimar Therapeutics is more favorable than Bright Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Health Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Larimar Therapeutics
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.11

Larimar Therapeutics has a net margin of 0.00% compared to Bright Health Group's net margin of -85.40%. Bright Health Group's return on equity of 0.00% beat Larimar Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bright Health Group-85.40% N/A -10.26%
Larimar Therapeutics N/A -52.48%-46.08%

Bright Health Group has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Larimar Therapeutics has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

In the previous week, Larimar Therapeutics had 2 more articles in the media than Bright Health Group. MarketBeat recorded 2 mentions for Larimar Therapeutics and 0 mentions for Bright Health Group. Larimar Therapeutics' average media sentiment score of 0.63 beat Bright Health Group's score of 0.00 indicating that Larimar Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Bright Health Group Neutral
Larimar Therapeutics Positive

Summary

Larimar Therapeutics beats Bright Health Group on 10 of the 16 factors compared between the two stocks.

Get Bright Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHG vs. The Competition

MetricBright Health GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$54.52M$54.52M$5.62B$20.73B
Dividend YieldN/AN/A5.24%3.71%
P/E Ratio-0.03N/A28.1327.84
Price / Sales0.020.02428.2642.30
Price / CashN/AN/A37.4622.63
Price / Book-0.27N/A8.044.57
Net Income-$1.46B-$1.46B$3.18B$989.30M
7 Day Performance-0.58%-0.58%3.62%0.20%
1 Month Performance0.29%0.29%4.06%3.95%
1 Year Performance34.98%34.98%30.01%10.27%

Bright Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHG
Bright Health Group
N/A$6.83
+0.4%
N/A+33.3%$54.52M$2.76B-0.032,840
LRMR
Larimar Therapeutics
1.9738 of 5 stars
$3.32
+3.8%
$18.50
+457.2%
-65.5%$212.58MN/A-2.2330
CRGX
CARGO Therapeutics
2.2334 of 5 stars
$4.58
+4.3%
$15.40
+236.2%
-73.3%$211.18MN/A-0.99116News Coverage
Analyst Forecast
High Trading Volume
MDWD
MediWound
1.8474 of 5 stars
$19.38
+0.6%
$31.80
+64.1%
-0.3%$209.46M$19.21M-9.2780
SCPH
scPharmaceuticals
4.5046 of 5 stars
$3.96
+2.6%
$14.00
+253.5%
-4.8%$209.05M$36.33M-2.0730Positive News
SLS
SELLAS Life Sciences Group
0.3433 of 5 stars
$2.09
-3.7%
N/A+60.0%$208.54M$1M-5.5010
ACIU
AC Immune
2.251 of 5 stars
$2.07
+4.0%
$12.00
+479.7%
-42.5%$207.85M$31.02M-3.57140Positive News
Analyst Revision
DSGN
Design Therapeutics
0.6364 of 5 stars
$3.64
+2.8%
$4.00
+9.9%
-7.5%$206.64MN/A-3.6840News Coverage
KOD
Kodiak Sciences
4.0934 of 5 stars
$3.90
+5.1%
$9.00
+130.8%
+64.1%$205.76MN/A-1.0790News Coverage
SXTC
China SXT Pharmaceuticals
0.8879 of 5 stars
$1.77
+4.7%
N/A-81.6%$205.37M$1.93M0.0090Gap Down
ELDN
Eledon Pharmaceuticals
1.5345 of 5 stars
$3.42
+10.0%
$9.00
+163.2%
+38.5%$204.79MN/A-1.6310Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NYSE:BHG) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners